Pain pumps have been used to treat post-surgical pain for years, as they are considered a safe alternative to the possible side effects of oral pain killers. Unfortunately, the FDA warns pain pumps may be associated with the risk of a rare, but painful condition called Postarthroscopic Glenohumeral Chondrolysis (PAGCL), which leads to the permanent deterioration of cartilage, often requiring additional surgeries and even complete replacement of the joint.

What You Can Do & How We Can Help

The Schmidt Firm, LLP is currently accepting pain pump induced injury cases in all 50 states. If you or somebody you know has been injured by a pain pump, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Product Liability Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Pain Pumps: An Overview

Anesthetic infusion devices, more widely known as pain pumps, are commonly used following surgical procedures in order to reduce pain. They can be used from anywhere between a few hours to a few days after surgery. Pain pumps consist of a pump and a catheter, which is placed in the joint of the surgical site. The pump automatically releases medication, which is delivered to the joint space by the catheter. Due to their close proximity to the actual injury, pain pumps are considered advantageous because they require smaller doses of pain medications, compared to oral drugs.

However, the pain pumps were never approved by the FDA. Instead, the FDA warn pain pumps may actually cause permanent injury to patients, especially following shoulder or knee surgeries. While the exact cause is not known, the anesthetic drugs, device material or another factor used in the pain pumps may have all caused the painful condition called Postarthroscopic Glenohumeral Chondrolysis (PAGCL), which is characterized by permanent cartilage deterioration, which may require additional surgeries or even a complete joint replacement.

Due to the severity of these permanent side effects, pain pump patients may want to contact a pain pump lawyer at The Schmidt Firm, LLP for a free case evaluation to discuss the potential for a pain pump lawsuit.

Pain Pump Side Effects

Patients suffering Postarthroscopic Glenohumeral Chondrolysis may experience the following symptoms:

• Pain (even while sleeping or motionless)
• Grinding
• Stiffness
• Clicking
• Popping
• Weakness
• Decreased Range of Motion

FDA warning

In early 2010, the FDA released a safety alert to doctors and patients warning of the correlation between pain pumps and Postarthroscopic Glenohumeral Chondrolysis.

In the report, the FDA cited a review of 35 cases of Postarthroscopic Glenohumeral Chondrolysis between 2006 and 2008. Of the 35 cases, 34 of them occurred in the shoulder after a previous shoulder surgery. The other case occurred in the knee joint, following a knee surgery. Pain, stiffness and loss of motion were reported by patients within 2 months of their surgery and PAGCL was diagnosed an average of 8.5 months after surgery. Of the patients who developed chondrolysis after surgery, half of them required follow up surgery.

Additionally, six of the cases involved pediatric patients between the ages of 16-18.

In their findings, the FDA noted that pain pumps are usually filled with anesthetics (numbing medications). The FDA explained anesthetics are only FDA approved for local or regional anesthesia or analgesia (pain killing), given at a superficial injection level. They are not FDA approved for continuous intra-articular infusions (to be used in pain pumps that go directly to the joint).

As the FDA stated, “Neither local anesthetics nor infusion devices (pain pumps) are FDA approved to be used for continuous intra-articular infusion (inside the joint). . . Health care professionals are encouraged to follow the instructions for use of elastomeric infusion devices (pain pumps), and to not use these devices for continuous intra-articular infusion of local anesthetics after orthopedic surgery.”

Postarthroscopic Glenohumeral Chondrolysis

Postarthoroscopic Glenohumeral Chondrolysis, also referred to as PAGCL or chondrolysis, is the deterioration of cartilage material. The word “chrondrolysis” describes cells in cartilage that once dead, cannot regenerate. As the cartilage wears away, it leaves nothing behind in the joint besides bone. As a result, it causes bone to rub against bone, which is extremely painful.

Due to the nature of the symptoms, PAGC is a severe and life-threatening condition.

Treatment of PAGCL is difficult. While anti-inflammatories and other medications may provide limited relief, ultimately patients may need to undergo complete joint replacement surgery.

Cause of Postarthroscopic Glenohumeral Chondrolysis

The exact cause of Postarthroscopic Glenohumeral Chondrolysis is unknown. It cannot be traced back to one specific aspect of pain pumps, although there is a correlation between the two.

The FDA advised that it may be caused by the anesthetic drugs, device material or other factors in the pain pump. One possible explanation is that the amounts of medication released were too high, often at lethal levels, which killed the cartilage material.

The following medications have been included in pain pumps:

• Bupivacaine
• Chlorprocaine
• Lidocaine
• Mepivacaine
• Procaine
• Ropivacaine

Unfortunately, the FDA cannot pinpoint the exact reason — whether medication caused or not — without further research. The FDA was clear, however, in recognizing that something in the pain pump system contributed to PAGCL after shoulder and knee surgeries.

Pain Pump Manufacturers

Since the FDA released information concerning pain pumps, many patients have filed lawsuits against pain pump makers, including the following list of pain pump manufacturers:

• Stryker
• DJO Inc.
• I-Flow Inc.
• BREG Inc.

Do I Have a Pain Pump Lawsuit?

The Schmidt Firm, LLP is currently accepting pain pump induced injury cases in all 50 states. If you or somebody you know has been injured by pain pump, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Product Liability Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Related Posts

• Shoulder Pain Pump Lawyer & Lawsuit
• Postarthroscopic Glenohumeral Chondrolysis Lawsuit